Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PROK — Prokidney Corp.

CIK 1446194 BALA CYNWYD, PA
Back to PROK Full portfolio

Position in PROK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$515,928
+$149,895 QoQ
Shares Held
252,906
+23.7% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 70 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PROK Over Time

Shares Held

Position Value (USD)

Derivatives in PROK

reported options exposure · as of Jun 30, 2026
CallValue
$127,500
CallShares
62,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. PROK ranks #159 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in PROK

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $127,500 62,500
2026-06-30 $515,928 252,906
2026-03-31 $366,033 204,488
2025-12-31 $893,491 398,880
2025-12-31 $287,840 128,500
2025-09-30 $617,109 255,004
2025-09-30 $437,052 180,600